nach oben

Erschienen in:

22.04.2022 | Original Article

Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS)

verfasst von: Ilaria Ruotolo, Giovanni Sellitto, Antonio Ianniello, Nikolaos Petsas, Letizia Castelli, Giovanni Galeoto, Anna Berardi, Valeria Barletta, Antonella Conte, Carlo Pozzilli

Erschienen in: Neurological Sciences | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Fatigue is a disabling symptom of multiple sclerosis (MS) and impacts on daily life. The Fatigue Symptoms and Impacts Questionnaire-Relapsing Multiple Sclerosis (FSIQ-RMS) is a new 20-item tool that investigates the aspects of fatigue in MS. It concerns motor, cognitive, social, and emotional aspects of fatigue. We aim at validating the Italian version of FSIQ-RMS in an Italian population of MS patients and demonstrate its reliability and construct validity.

Methods

We included patients with diagnosis of MS, age between 18 and 70 years with ability to participate in a 90-min interview. Each patient completed the Italian version of FSIQ-RMS and Fatigue Severity Scale (FSS) at the same time. Construct validity was explored by the exploratory factor analysis; reliability was assessed with Cronbach’s alpha; and test–retest stability was examined through intraclass correlation coefficient (ICC). Concurrent validity was calculated using Pearson’s correlation.

Results

We enrolled 171 patients (126 female and 45 male), 83% with relapsing MS (RMS), and 17% with secondary progressive MS (SPMS). Italian FSIQ-RMS showed a Cronbach’s alpha of 0.92; ICC was 0.96. Pearson’s correlation coefficient between FSIQ-RMS and FSS total score was statistically significant (p < 0.01); FSIQ-RMS inversely correlated also with BMI and positively with EDSS.

Conclusion

The Italian version of FSIQ-RMS has excellent psychometric properties and can be used in research and clinical setting to evaluate physical, cognitive, and social fatigue in both RMS and SPMS.

Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ (1994) The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci J Can Sci Neurol 21:9–14CrossRef

Sellitto G, Morelli A, Bassano S, Conte A, Baione V, Galeoto G, Berardi A (2021) Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review. Expert Rev Pharmacoecon Outcomes Res 21:625–646. https://doi.org/10.1080/14737167.2021.1883430CrossRefPubMed

Walker LAS, Berard JA, Berrigan LI, Rees LM, Freedman MS (2012) Detecting cognitive fatigue in multiple sclerosis: method matters. J Neurol Sci 316:86–92. https://doi.org/10.1016/j.jns.2012.01.021CrossRefPubMed

Greeke EE, Chua AS, Healy BC, Rintell DJ, Chitnis T, Glanz BI (2017) Depression and fatigue in patients with multiple sclerosis. J Neurol Sci 380:236–241. https://doi.org/10.1016/j.jns.2017.07.047CrossRefPubMed

Olascoaga J (2010) Quality of life and multiple sclerosis. Rev Neurol 51:279–288PubMed

Colosimo C, Millefiorini E, Grasso MG, Vinci F, Fiorelli M, Koudriavtseva T, Pozzilli C (2009) Fatigue in MS is associated with specific clinical features. Acta Neurol Scand 92:353–355. https://doi.org/10.1111/j.1600-0404.1995.tb00145.xCrossRef

Schwid SR, Covington M, Segal BM, Goodman AD (2002) Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev 39:211–224PubMed

Brañas P, Jordan R, Fry-Smith A, Burls A, Hyde C (2000) Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess Winch Engl 4:1–61

Enoka RM, Almuklass AM, Alenazy M, Alvarez E, Duchateau J (2021) Distinguishing between fatigue and fatigability in multiple sclerosis. Neurorehabil Neural Repair 35:960–973. https://doi.org/10.1177/15459683211046257CrossRefPubMed

10.

Tommasin S, De Luca F, Ferrante I, Gurreri F, Castelli L, Ruggieri S, Prosperini L, Pantano P, Pozzilli C, De Giglio L (2020) Cognitive fatigability is a quantifiable distinct phenomenon in multiple sclerosis. J Neuropsychol 14:370–383. https://doi.org/10.1111/jnp.12197CrossRefPubMed

11.

Mackay L, Johnson AM, Moodie ST, Rosehart H, Morrow SA (2021) Predictors of cognitive fatigue and fatigability in multiple sclerosis. Mult Scler Relat Disord 56:103316. https://doi.org/10.1016/j.msard.2021.103316CrossRefPubMed

12.

Bailey A, Channon S, Beaumont JG (2007) The relationship between subjective fatigue and cognitive fatigue in advanced multiple sclerosis. Mult Scler Houndmills Basingstoke Engl 13:73–80. https://doi.org/10.1177/1352458506071162CrossRef

13.

van Geest Q, Douw L, van ‘t Klooster S, Leurs CE, Genova HM, Wylie GR, Steenwijk MD, Killestein J, Geurts JJG, Hulst HE (2018) Information processing speed in multiple sclerosis: relevance of default mode network dynamics. NeuroImage Clin 19:507–515. https://doi.org/10.1016/j.nicl.2018.05.015CrossRefPubMedPubMedCentral

14.

Khan F, Amatya B, Galea M (2014) Management of fatigue in persons with multiple sclerosis. Front Neurol 5. https://doi.org/10.3389/fneur.2014.00177

15.

Lerdal A, Celius EG, Moum T (2003) Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Mult Scler Houndmills Basingstoke Engl 9:509–514. https://doi.org/10.1191/1352458503ms943oaCrossRef

16.

Krupp LB (1989) The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121. https://doi.org/10.1001/archneur.1989.00520460115022CrossRefPubMed

17.

Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF (1994) Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale. Clin Infect Dis 18:S79–S83. https://doi.org/10.1093/clinids/18.Supplement_1.S79CrossRefPubMed

18.

Kos D, Kerckhofs E, Carrea I, Verza R, Ramos M, Jansa J (2005) Evaluation of the Modified Fatigue Impact Scale in four different European countries. Mult Scler Houndmills Basingstoke Engl 11:76–80. https://doi.org/10.1191/1352458505ms1117oaCrossRef

19.

Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J, Eckert B (2009) The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS). Mult Scler Houndmills Basingstoke Engl 15:1228–1238. https://doi.org/10.1177/1352458509106714CrossRef

20.

Penner IK, Raselli C, Stöcklin M, Opwis K, Kappos L, Calabrese P (2009) The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler Houndmills Basingstoke Engl 15:1509–1517. https://doi.org/10.1177/1352458509348519CrossRef

21.

Mills RJ, Young CA, Pallant JF, Tennant A (2010) Development of a patient reported outcome scale for fatigue in multiple sclerosis: the Neurological Fatigue Index (NFI-MS). Health Qual Life Outcomes 8:22. https://doi.org/10.1186/1477-7525-8-22CrossRefPubMedPubMedCentral

22.

Mills RJ, Young CA (2007) A medical definition of fatigue in multiple sclerosis. QJM 101:49–60. https://doi.org/10.1093/qjmed/hcm122CrossRef

23.

Hudgens S, Schüler R, Stokes J, Eremenco S, Hunsche E, Leist TP (2019) Development and validation of the FSIQ-RMS: a new patient-reported questionnaire to assess symptoms and impacts of fatigue in relapsing multiple sclerosis. Value Health 22:453–466. https://doi.org/10.1016/j.jval.2018.11.007CrossRefPubMed

24.

Kappos L, Fox RJ, Burcklen M, Freedman MS, Havrdová EK, Hennessy B, Hohlfeld R, Lublin F, Montalban X, Pozzilli C, Scherz T, D’Ambrosio D, Linscheid P, Vaclavkova A, Pirozek-Lawniczek M, Kracker H, Sprenger T (2021) Ponesimod compared with teriflunomide in patients with relapsing multiple sclerosis in the active-comparator phase 3 OPTIMUM study: a randomized clinical trial. JAMA Neurol 78:558. https://doi.org/10.1001/jamaneurol.2021.0405CrossRefPubMed

25.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173. https://doi.org/10.1016/S1474-4422(17)30470-2CrossRefPubMed

26.

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1444. https://doi.org/10.1212/WNL.33.11.1444CrossRefPubMed

27.

Lohr KN, Aaronson NK, Alonso J, Audrey Burnam M, Patrick DL, Perrin EB, Roberts JS (1996) Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther 18:979–992. https://doi.org/10.1016/S0149-2918(96)80054-3CrossRefPubMed

28.

Lohr KN (2002) [No title found]. Qual Life Res 11:193–205. https://doi.org/10.1023/A:1015291021312

29.

Laing CM, Cooper CL, Summers F, Lawrie L, O’Flaherty S, Phillips LH (2020) The nature of anger in people with multiple sclerosis: a qualitative study, Psychol. Health 35:824–837. https://doi.org/10.1080/08870446.2019.1691726CrossRef

30.

Eizaguirre MB, Ciufia N, Roman MS, Martínez Canyazo C, Alonso R, Silva B, Pita C, Garcea O, Vanotti S (2020) Perceived fatigue in multiple sclerosis: the importance of highlighting its impact on quality of life, social network and cognition. Clin Neurol Neurosurg 199:106265. https://doi.org/10.1016/j.clineuro.2020.106265CrossRefPubMed

31.

Patrick E, Christodoulou C, Krupp LB (2009) New York State MS Consortium, Longitudinal correlates of fatigue in multiple sclerosis. Mult Scler Houndmills Basingstoke Engl 15:258–261. https://doi.org/10.1177/1352458508097466CrossRef

32.

Bisht B, Darling WG, Grossmann RE, Shivapour ET, Lutgendorf SK, Snetselaar LG, Hall MJ, Zimmerman MB, Wahls TL (2014) A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med 20:347–355. https://doi.org/10.1089/acm.2013.0188CrossRefPubMedPubMedCentral

33.

Hoang PD, Lord S, Gandevia S, Menant J (2021) Exercise and Sports Science Australia (ESSA) position statement on exercise for people with mild to moderate multiple sclerosis. J Sci Med Sport S1440244021002140. https://doi.org/10.1016/j.jsams.2021.08.015

34.

Lee JE, Bisht B, Hall MJ, Rubenstein LM, Louison R, Klein DT, Wahls TL (2017) A Multimodal, nonpharmacologic intervention improves mood and cognitive function in people with multiple sclerosis. J Am Coll Nutr 36:150–168. https://doi.org/10.1080/07315724.2016.1255160CrossRefPubMed

35.

Fortune J, Norris M, Stennett A, Kilbride C, Lavelle G, Hendrie W, Victor C, Ryan JM (2021) Patterns and correlates of sedentary behaviour among people with multiple sclerosis: a cross-sectional study. Sci Rep 11:20346. https://doi.org/10.1038/s41598-021-99631-zCrossRefPubMedPubMedCentral

36.

Redlicka J, Zielińska-Nowak E, Lipert A, Miller E (2021) Impact of moderate individually tailored physical activity in multiple sclerosis patients with fatigue on functional, cognitive, emotional state, and postural stability. Brain Sci 11:1214. https://doi.org/10.3390/brainsci11091214CrossRefPubMedPubMedCentral

37.

Giovannoni G (2006) Multiple sclerosis related fatigue. J Neurol Neurosurg Psychiatry 77:2–3. https://doi.org/10.1136/jnnp.2005.074948CrossRefPubMedPubMedCentral

Titel: Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS)
verfasst von: Ilaria Ruotolo
Giovanni Sellitto
Antonio Ianniello
Nikolaos Petsas
Letizia Castelli
Giovanni Galeoto
Anna Berardi
Valeria Barletta
Antonella Conte
Carlo Pozzilli
Publikationsdatum: 22.04.2022
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 8/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06080-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2022

The prediction effects of thyroid function in the severity of Guillain-Barré syndrome

Longitudinally extensive dorsal column spinal cord lesion with sensory ganglionopathy

The first case report of spinocerebellar ataxia type-40 in India: novel phenotypic and radiological (bilateral olivary degeneration) features and a comprehensive review of this remarkable radiological sign

Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience

Validation of a short Italian version of the Barratt Impulsiveness Scale (BIS-15) in non-clinical subjects: psychometric properties and normative data